SWOG Cancer Research Network: Colorectal Neoplasms trials
The registry lists 12 Colorectal Neoplasms studies with SWOG Cancer Research Network as lead sponsor. 1 are open to participants now and 2 have results posted.
Phase 2 7Phase 3 2No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer SurvivorsRecruitingNCT07018869Phase 3
- S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)CompletedNCT02728596Not applicableResults posted
- S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal CancerCompletedNCT02164916Phase 2Results posted
- S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer SurvivorsCompletedNCT01453452Not applicable
- S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib HydrochlorideCompletedNCT01416688
- S0820, Adenoma and Second Primary Prevention TrialActive, not recruitingNCT01349881Phase 3
- S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal CancerWithdrawnNCT00118105Phase 2
- FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal CancerCompletedNCT00077337Phase 2
- S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the RectumWithdrawnNCT00070434Phase 2
- S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically RemovedCompletedNCT00049335Phase 2
- S9923 R115777 in Treating Patients With Advanced Colorectal CancerCompletedNCT00005833Phase 2
- SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to FluorouracilCompletedNCT00003254Phase 2